Received May 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
received a dose of Shingrix reconstituted with sterile water; received a dose of Shingrix reconstituted with sterile water; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: received a dose of Shingrix reconstituted with sterile water) and inappropriate dose of vaccine administered (Verbatim: received a dose of Shingrix reconstituted with sterile water). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 21-APR-2025 The director of pharmacy called to report that they administered Shingrix reconstituted with sterile water to a patient over 50 years old which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter had a questioned was there any guidance or did the patient needs another dose.